Literature DB >> 31668061

Polymer-Mediated Penetration-Independent Cancer Therapy.

Jianxun Ding1, Xiangru Feng1, Zhongyu Jiang1, Weiguo Xu1, Hui Guo1, Xiuli Zhuang1, Xuesi Chen1.   

Abstract

The development of polymer-based drug delivery systems provides efficient modalities for cancer therapy. Most of the polymer pharmaceuticals target cancer cells directly, but the insufficient penetration always results in unsatisfactory anticancer efficacy. To break the above bottleneck, strategies of penetration-independent cancer therapy have been developed as advanced treatments for various cancers in the past decade. In this Perspective, we discussed the pros and cons of polymer-mediated biological and physical penetration-independent approaches for cancer therapy and highlighted their further prospects from bench to bedsides.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31668061     DOI: 10.1021/acs.biomac.9b01263

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  4 in total

Review 1.  Implantable and Injectable Biomaterial Scaffolds for Cancer Immunotherapy.

Authors:  Jie Li; Yiqian Luo; Baoqin Li; Yuanliang Xia; Hengyi Wang; Changfeng Fu
Journal:  Front Bioeng Biotechnol       Date:  2020-11-30

2.  Molecular Targeted Agent and Immune Checkpoint Inhibitor Co-Loaded Thermosensitive Hydrogel for Synergistic Therapy of Rectal Cancer.

Authors:  Huaiyu Zhang; Jiayu Zhang; Yilun Liu; Yang Jiang; Zhongmin Li
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

3.  The protein corona reduces the anticancer effect of graphene oxide in HER-2-positive cancer cells.

Authors:  Lishan Cui; Erica Quagliarini; Siyao Xiao; Francesca Giulimondi; Serena Renzi; Luca Digiacomo; Giulio Caracciolo; Junbiao Wang; Augusto Amici; Cristina Marchini; Daniela Pozzi
Journal:  Nanoscale Adv       Date:  2022-08-24

4.  Effective Targeting of Colon Cancer Cells with Piperine Natural Anticancer Prodrug Using Functionalized Clusters of Hydroxyapatite Nanoparticles.

Authors:  Khaled AbouAitah; Agata Stefanek; Iman M Higazy; Magdalena Janczewska; Anna Swiderska-Sroda; Agnieszka Chodara; Jacek Wojnarowicz; Urszula Szałaj; Samar A Shahein; Ahmed M Aboul-Enein; Faten Abou-Elella; Stanislaw Gierlotka; Tomasz Ciach; Witold Lojkowski
Journal:  Pharmaceutics       Date:  2020-01-16       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.